Clinically meaningful changes in functional status in patients with ankylosing spondylitis receiving etanercept (Enbrel®) or placebo

被引：0
|
作者：
Singh, A [1 ]
Wajdula, J [1 ]
Fatenejad, S [1 ]
机构：
[1] Wyeth Ayerst Res, Collegeville, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S233 / S233
页数：1
相关论文
共 50 条
  • [1] The effects of etanercept on the functional status of subjects with ankylosing spondylitis
    van der Heijde, DM
    Woolley, JM
    Tsuji, W
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 243 - 244
  • [2] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN EUROPE
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Baynton, E.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A522 - A523
  • [3] Baseline factors influential on ASAS 20 response in ankylosing spondylitis patients treated with etanercept (ENBREL®)
    Davis, JC
    van der Heijde, DM
    Dougados, M
    Braun, J
    Cush, JJ
    Clegg, DO
    Inman, RD
    Devries, T
    Tsuji, WH
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S440 - S440
  • [4] A multicientre, placebo-controlled trial of enbrel in ankylosing spondylitis
    Calin, A
    Dijkmans, B
    Emery, P
    Hakala, M
    Kalden, J
    Leirisalo-Repo, M
    Mola, EM
    Salvarani, C
    Sanmarti, R
    Sany, J
    Sibilia, J
    Sieper, J
    Van der Linden, S
    Veys, E
    Appel, A
    Fatenejad, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 95 - 95
  • [5] Sustained efficacy of etanercept (Enbrel®) in ankylosing spondylitis up to 18 months.
    Davis, JC
    van der Heijde, DM
    Braun, J
    Dougados, M
    Cush, JJ
    Clegg, DO
    Kivitz, AJ
    Inman, RD
    Whitmore, J
    Tsuji, W
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S611 - S611
  • [6] Efficacy of etanercept (Enbrel®) in the treatment of ankylosing spondylitis:: A randomized, placebo-controlled, double-blind study.
    Gorman, JD
    Sack, KE
    Davis, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2947 - 2947
  • [7] Biologics in ankylosing spondylitis (AS): Definition of clinically meaningful improvement
    Stone, M
    Inman, R
    Maetzel, A
    [J]. JOURNAL OF RHEUMATOLOGY, 2003, 30 (08) : 1887 - 1887
  • [8] Radiographic results from a long-term multicenter trial of etanercept (ENBREL®) in patients with ankylosing spondylitis
    van der Horst-Bruinsma, I.
    Wanders, A.
    van der Heijde, D.
    Fatenejad, S.
    [J]. RHEUMATOLOGY, 2006, 45 : I5 - I5
  • [9] COMPARISON OF DISEASE STATUS AND OUTCOMES OF PATIENTS WITH ANKYLOSING SPONDYLITIS (AS) RECEIVING ADALIMUMAB OR ETANERCEPT MONOTHERAPY IN THE UNITED STATES (US)
    Narayanan, S.
    Lu, Y.
    Hutchings, R.
    Graham, C. M.
    Baynton, E.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A292 - A293
  • [10] Radiographic results from a long-term multicenter trial of etanercept ENBREL®) in patients with Ankylosing Spondylitis.
    Dijkmans, B
    Wanders, A
    van der Heijde, D
    Fatenejad, S
    Afdeling, R
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S634 - S634
12345